| 2026-08-10 | Press release | Tonix Pharmaceuticals Reports Second Quarter 2026 Financial Results and Operational Highlights |
| 2026-08-10 | Earnings deck | 2Q'26 Call Presentation |
| 2026-08-05 | Press release | Tonix Pharmaceuticals to Participate in Upcoming Investor Conferences |
| 2026-08-03 | Press release | Tonix Pharmaceuticals Announces Positive Minutes from Type C FDA Meeting to Discuss Adaptive Phase 2 Field Study of TNX- |
| 2026-08-03 | Presentation | TNX-4800 for Lyme Disease Prevention in the U.S. |
| 2026-07-27 | Press release | Tonix Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 10, 2026 |
| 2026-07-15 | Press release | Tonix Pharmaceuticals Announces Publication in the Peer-Reviewed Journal of Virology Assessing Virulence of the 2022 Out |
| 2026-07-13 | Press release | Tonix Pharmaceuticals Announces Major Managed Medicare Payer Agreement for TONMYA® |
| 2026-06-29 | Press release | Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 HORIZON Study of TNX-102 SL for the Treatment of Major |
| 2026-06-11 | Press release | Tonix Pharmaceuticals to Attend BTIG Infectious Disease Day 2026 |
| 2026-06-08 | Press release | Tonix Pharmaceuticals Secures Second Commercial Payer Agreement for TONMYA®, Expanding Total Commercial Coverage to ~52 |
| 2026-05-28 | Press release | Tonix Pharmaceuticals Presented Retrospective U.S. Real-World Claims Analysis of Opioid Use in Patients with Fibromyalgi |
| 2026-05-17 | Presentation | TNX-1500 for Prevention of Kidney Transplant Rejection and Autoimmune Disorders: 2nd Richard Slayman Clinical Xenotransp |
| Press release | HTML |
| 2026-05-11 | Press release | PDF |
| Presentation | Tonix Pharmaceuticals Announces Oral Presentation and Two Poster Presentations on Preclinical Immuno-oncology Portfolio |
| 2026-03-12 | Press release | Earnings Release |
| Press release | Tonix Pharmaceuticals Presented Post Hoc Analyses of Phase 3 Data on TONMYA™ at the 8th International Congress on Contro |
| 2026-01-06 | Press release | Tonix Pharmaceuticals to Present at Two Investor Conferences in January 2026 |
| Press release | Tonix Pharmaceuticals Reports Third Quarter 2025 Financial Results and Operational Highlights |
| Press release | Tonix Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operational Highlights |
| Press release | Tonix Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Highlights |
| 2025-03-18 | Press release | Earnings Release |
| 2025-03-18 | Press release | Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights |
| 2025-03-18 | Press release | PDF: Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights |
| 2024-11-12 | Press release | Earnings Release |
| 2024-11-12 | Press release | PDF: Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights |
| 2024-08-19 | Press release | Earnings Release |
| 2024-08-19 | Press release | PDF: Tonix Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operational Highlights |
| 2024-05-13 | Press release | Earnings Release |
| 2024-04-01 | Press release | Earnings Release |
| 2023-11-09 | Press release | Earnings Release |
| 2023-08-10 | Press release | Earnings Release |
| 2023-05-08 | Press release | Earnings Release |
| 2023-03-13 | Press release | Earnings Release |
| 2022-11-07 | Press release | Earnings Release |
| 2022-08-08 | Press release | Earnings Release |
| 2022-05-09 | Press release | Earnings Release |
| 2022-03-14 | Press release | Earnings Release |
| 2021-11-08 | Press release | Earnings Release |